Search results for "Stroke"
Closing the gap on osteoporosis
A new clinical guideline from ACP focuses on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults.
https://immattersacp.org/archives/2023/05/closing-the-gap-on-osteoporosis.htm
1 May 2023
Stepping up to treat osteoporosis
This month's issue addresses osteoporosis, transient ischemic attacks, and another edition of I.M. Ready columns for early career physicians.
https://immattersacp.org/archives/2023/05/stepping-up-to-treat-osteoporosis.htm
1 May 2023
Large review compares benefits, harms of drugs to treat type 2 diabetes
High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://immattersacp.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023
Only half of patients with mood problems after stroke receive mental health care
Factors associated with receiving post-stroke mental health care included pre-stroke mental health care, younger age at stroke, and female gender, a retrospective study in Australia found.
https://immattersacp.org/weekly/archives/2023/04/04/4.htm
4 Apr 2023
Over-the-counter test for flu, COVID-19 authorized
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/04/over-the-counter-test-for-flu-covid-19-authorized.htm
1 Apr 2023
MKSAP Quiz: Motivating lifestyle change
A 28-year-old man is evaluated during a follow-up visit for hypertension and diabetes mellitus. He works two jobs and eats fast food for most meals. Which of the following is the most appropriate management?
https://immattersacp.org/weekly/archives/2023/03/21/3.htm
21 Mar 2023
Separate industry-funded studies find benefit to bempedoic acid as preventive medication, CRP as biomarker
Bempedoic acid reduced cardiovascular (CV) events among patients unwilling or unable to take statins, a trial found, while a review showed that high-sensitivity C-reactive protein (CRP) was a stronger predictor for risk of future CV events and death than cholesterol in patients on statins.
https://immattersacp.org/weekly/archives/2023/03/14/4.htm
14 Mar 2023
Getting to know GLP-1 receptor agonists
Choosing among glucagon-like peptide-1 (GLP-1) receptor agonists depends on many factors, such as the desired outcome and individual risks among patients.
https://immattersacp.org/archives/2023/03/getting-to-know-glp-1-receptor-agonists.htm
1 Mar 2023
Anticholinergic drugs associated with lower cognitive function
A retrospective study of patients ages 45 years and older found an association between anticholinergic drugs and cognition but also a role for physical activity in mitigating the relationship between these medications and cognitive decline.
https://immattersacp.org/weekly/archives/2023/02/21/4.htm
21 Feb 2023
Incidentally detected bradyarrhythmias not associated with worse outcomes in older patients
Bradyarrhythmias were found in 20.8% of patients ages 70 years and older who were given an implantable loop recorder compared to 3.8% in a control group, but detection and treatment were not associated with risk of syncope or sudden death, a Danish study found.
https://immattersacp.org/weekly/archives/2023/02/21/1.htm
21 Feb 2023